Finch Therapeutics Added to Russell 2000 and Russell 3000 Indexes
Finch Therapeutics to Present at Upcoming Virtual Investor Conferences
Finch Therapeutics Reports First Quarter 2021 Financial Results and Provides Business Updates
Finch Therapeutics to Participate in the BofA Securities 2021 Virtual Health Care Conference
Finch Therapeutics Appoints Susan E. Graf to Board of Directors
Finch Therapeutics to Participate in the Jefferies Microbiome-Based Therapeutics Summit
Finch Therapeutics Announces Pricing of Upsized Initial Public Offering
